1. Home
  2. Analysis
  3. Rapamune
  4. Proair-hfa

Rapamune and Proair hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 39 people who take Rapamune and Proair hfa. Common interactions include back pain among females, and platelet count decreased among males.

The phase IV clinical study analyzes what interactions people who take Rapamune and Proair hfa have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2023

39 people who take Rapamune and Proair hfa together, and have interactions are studied.

What is Rapamune?

Rapamune has active ingredients of sirolimus. It is used in kidney transplant. Currently, eHealthMe is studying from 13,735 Rapamune users.

What is Proair hfa?

Proair hfa has active ingredients of albuterol sulfate. It is used in asthma. Currently, eHealthMe is studying from 51,358 Proair hfa users.

Number of Rapamune and Proair hfa reports submitted per year:

Rapamune and Proair hfa drug interactions.

Common Rapamune and Proair Hfa drug interactions by gender *:

female:

  1. Back pain
  2. Cataract
  3. Cytomegalovirus infection
  4. Herpes zoster
  5. Skin lesion
  6. Accident
  7. Concussion
  8. Contusion
  9. Dizziness
  10. Musculoskeletal pain

male:

  1. Platelet count decreased
  2. Death
  3. Drug ineffective
  4. Gingival swelling
  5. Haematoma
  6. Haemoptysis
  7. Mood altered
  8. Plasma cell myeloma
  9. Thrombocytopenia
  10. Pneumonia

Common Rapamune and Proair Hfa drug interactions by age *:

0-1:

n/a

2-9:

  1. Death

10-19:

  1. Nasopharyngitis

20-29:

  1. Bone pain
  2. Depression
  3. Hypertension
  4. Neck pain
  5. Road traffic accident
  6. Weight increased

30-39:

n/a

40-49:

  1. Abdominal discomfort
  2. Anaemia
  3. Blood pressure increased
  4. Death
  5. Gingival swelling
  6. Thrombocytopenia

50-59:

  1. Back pain
  2. Cataract
  3. Cytomegalovirus infection
  4. Herpes zoster
  5. Skin lesion
  6. Platelet count decreased
  7. Pneumonia
  8. Constipation
  9. Drug ineffective
  10. Haematoma

60+:

  1. Accident
  2. Concussion
  3. Pyrexia
  4. Tongue ulceration
  5. Dysphonia
  6. Oral candidiasis
  7. Laceration
  8. Feeding disorder
  9. Gastrooesophageal reflux disease
  10. Eating disorder

Common conditions people have *:

  1. High Blood Cholesterol: 10 people, 25.64%
  2. Wheezing (a high-pitched whistling sound made while you breath): 9 people, 23.08%
  3. Cardiac Disorder: 8 people, 20.51%
  4. High Blood Pressure: 8 people, 20.51%
  5. Depression: 6 people, 15.38%
  6. Swelling: 5 people, 12.82%
  7. Anaemia (lack of blood): 5 people, 12.82%
  8. Blood Glucose Abnormal: 5 people, 12.82%
  9. Transplant Rejection (a transplant material is not worked): 5 people, 12.82%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 12.82%

* Approximation only. Some reports may have incomplete information.

Do you take Rapamune and Proair hfa?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Rapamune drug interactions:

Browse interactions between Rapamune and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Proair hfa drug interactions:

Browse interactions between Proair hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sirolimus and albuterol sulfate (the active ingredients of Rapamune and Proair hfa, respectively), and Rapamune and Proair hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Rapamune and Proair hfa.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.